PRAX vs RPRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

PRAX

37.6
AI Score
VS
PRAX Wins

RPRX

36.2
AI Score

Investment Advisor Scores

PRAX

38score
Recommendation
SELL

RPRX

36score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PRAX RPRX Winner
Net Income -214.36M 457.25M RPRX
Operating Income -229.15M 1.11B RPRX
ROE -62.4% 4.7% RPRX
ROA -54.1% 2.3% RPRX
Total Assets 396.39M 19.46B RPRX
Cash 149.53M 513.66M RPRX
Current Ratio 5.18 1.29 PRAX

Relative Price Performance (Last 90 Days)

PRAX 1M: +42.3% · 3M: -6.0% RPRX 1M: +23.8% · 3M: +19.6%

Current Technical Phase

PRAX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 70

RSI (14): 69.6 · Price: $346.21

RPRX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.6% over 20 days), RSI 79

RSI (14): 79.1 · Price: $70.01

Fundamentals Snapshot

Metric PRAX RPRX
Market Cap — —
Forward P/E -35.7 11.8
Trailing P/E — 45.4
Revenue (TTM) — —
Revenue Growth 13.5% 0.1%
Gross Margin -38.7% 1.0%
Operating Margin 0.0% 0.8%
EPS -12.82 1.53
Dividend Yield — 0.01%

Frequently Asked Questions

Based on our detailed analysis, PRAX is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.